CLINICAL_TRIALS
withdrawal
· 2012-12-07
Clinical Trial Update: Safety Study of ALG- 1001 to Treat Diabetic Macular Edema [Phase 1, Phase 2]
Summary
The Phase 1/2 safety trial of ALG-1001 for diabetic macular edema was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allegro Ophthalmics, LLC | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: WITHDRAWN